Your session is about to expire
Depakote vs Topamax
Introduction
For patients diagnosed with epilepsy or other types of seizure disorders, certain drugs designed to control the electrical activity in the brain can help stabilize and prevent seizures. Depakote and Topamax are two such medications often prescribed for these conditions. They each impact different aspects of neuronal functioning but both have shown efficacy in managing epileptic symptoms. Depakote, also known as divalproex sodium, is a type of drug called an anticonvulsant or anti-epileptic drug (AED) that increases levels of gamma-aminobutyric acid (GABA) in the brain, helping to calm excessive nerve firing associated with seizures. Topamax, on the other hand, is classified as both an AED and a carbonic anhydrase inhibitor; it primarily works by decreasing abnormal excitement in the brain.
Depakote vs Topamax Side By Side
Attribute | Depakote | Topamax |
---|---|---|
Brand Name | Depakote | Topamax |
Contraindications | Should not be taken with MAOIs, certain antidepressants, or other seizure medicines without consulting a physician. | Should not be taken with MAOIs, certain antidepressants, or other seizure medicines without consulting a physician. |
Cost | For brand name: around $650 for 60 tablets of 250 mg. Generic: $.40 to $3 per day based on typical dosages. | For brand name: about $375 for 30 tablets of 100 mg. Generic: $.20 to about $2 per day based on standard dosages. |
Generic Name | Divalproex Sodium | Topiramate |
Most Serious Side Effect | Unusual bruising or bleeding, liver damage | Signs of a severe allergic reaction, sudden vision loss, or thoughts of suicide. |
Severe Drug Interactions | Can interact dangerously with other medications like MAOIs and certain antidepressants. | Can interact dangerously with other medications like MAOIs and certain antidepressants. |
Typical Dose | Starts at 10-15 mg/kg/day, increased by 5-10 mg/kg/week, not to exceed 60mg/kg/day. | Starts at 25–50 mg/day, can be increased to 100 mg/day, with a maximum of 400 mg/day divided into two doses. |
What is Depakote?
Divalproex sodium (the generic name for Depakote) was one of the first drugs developed in the class of anticonvulsants, which marked a significant advance from earlier classes of seizure medications. Divalproex sodium was initially approved by the FDA in 1983. Depakote increases levels of gamma-Aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain, thereby reducing excitability and preventing seizures. It is prescribed for epilepsy and bipolar disorder, as well as prevention of migraines.
Depakote has a strong influence on GABA with only minor effects on other neurotransmitters like serotonin or norepinephrine, which results in it having fewer side effects than other anticonvulsants that have stronger effects on these two other neurotransmitters.
Topiramate (generic name Topamax), another popular drug within this class, operates differently from Depakote but serves similar purposes such as controlling seizures and preventing migraines. One key difference between them lies within their secondary uses; while both are used to manage seizures and prevent migraines, Topamax can also be used effectively to treat certain eating disorders due to its appetite-suppressing properties.
What conditions is Depakote approved to treat?
Depakote is approved for the treatment of various neurological and mood disorders, including:
- Epilepsy: used either alone or in combination with other drugs to control certain types of seizures
- Manic episodes associated with bipolar disorder
- Prevention of migraine headaches (not to treat migraines that have already begun)
How does Depakote help with these illnesses?
Depakote, also known as divalproex sodium, is an anticonvulsant medication that helps manage epilepsy and certain mood disorders by increasing the amount of gamma-aminobutyric acid (GABA) in the brain. GABA is a neurotransmitter - a chemical messenger in the brain - which inhibits nerve impulses, reducing activity in the central nervous system. By raising GABA levels, Depakote can limit seizures and help stabilize mood swings associated with conditions like bipolar disorder.
Topamax or topiramate, on the other hand, has a slightly different mechanism of action. It's believed to work by blocking voltage-dependent sodium channels and augmenting GABA activity. This dual-action approach not only reduces excessive electrical nerve activity that may trigger seizures but also enhances calming effects similar to Depakote.
Both medications are effective for managing neurological conditions; however their suitability will depend on individual patient factors such as side-effect profile tolerance and specific condition being treated.
What is Topamax?
Topamax is a brand name for topiramate, an anticonvulsant medication that helps to prevent seizures and reduce the frequency of migraines. It does this by stabilizing electrical activity in the brain, specifically by increasing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that sends signals throughout your nervous system. Topiramate also works as a carbonic anhydrase inhibitor which means it can slow down some reactions in your body that are accelerated during seizures or migraine attacks. Approved by the FDA in 1996, Topamax is not classified as a standard mood stabilizer like Depakote. Its unique method of action means its side-effects profile differs from traditional mood-stabilizers: common side effects include weight loss and cognitive issues such as difficulty with memory or concentration. Topamax's effect on GABA can be beneficial especially for patients who do not respond well to typical mood-stabilizing drugs such as Depakote.
What conditions is Topamax approved to treat?
Topamax is an anticonvulsant medication that has gained FDA approval for the management of several conditions, including:
- Epilepsy: it can either be used alone or as part of combination therapy to manage seizures.
- Migraine prevention: Topamax helps reduce the frequency and intensity of migraines in people who experience this condition regularly.
How does Topamax help with these illnesses?
Topiramate, commonly known as Topamax, is a medication that has demonstrated effectiveness in controlling seizures and migraines. It works by calming hyperactive electrical signals in the brain which can cause seizures. This function is similar to the neurotransmitter GABA's action on neuronal excitability, leading to decreased nerve firing and ultimately reducing seizure activity or migraine frequency. In contrast to Depakote, which also acts on GABA receptors but may have more side effects such as weight gain and potential liver damage, Topamax is often chosen for its lower risk profile and additional benefit of promoting weight loss. Furthermore, it's not uncommon for patients who don't respond well to other anti-convulsant medications like Depakote to be switched onto or combined with Topamax in their treatment plan.
How effective are both Depakote and Topamax?
Both divalproex sodium (Depakote) and topiramate (Topamax) have a proven track record of successfully treating patients with seizure disorders, and they were approved by the FDA within a few years of each other. As they act on different mechanisms within the brain, their prescription may depend on individual patient needs. A 2008 study evaluated the effectiveness of these two drugs in controlling seizures; both medications exhibited comparable efficacy in managing symptoms as well as similar safety profiles. This trial did not find any significant differences between patients receiving Depakote and those given Topamax based on various metrics used to measure efficacy in controlling seizures.
In clinical practice, it appears that Depakote is more often prescribed than Topamax for generalized or unclassified epilepsy. Furthermore, a review published in 2013 suggests that Depakote begins alleviating epileptic symptoms soon after treatment initiation and its side effect profile is considered manageable compared to many other anti-epileptic drugs . It has also been found tolerable across diverse populations including pediatric and geriatric groups.
A 2015 meta-analysis indicated that while Topamax seems to be effective against focal-onset seizures when compared to placebo, evidence comparing it directly with other common antiepileptics remains inconclusive. Even so, due to its unique mechanism of action blocking voltage-dependent sodium channels while simultaneously enhancing GABA activity -the main inhibitory neurotransmitter-, Topamax might be an optimal choice for patients who do not respond well or are intolerant towards first-line treatments like Depakote. The same goes for those who need an additional drug alongside their existing regimen because monotherapy proved insufficient at controlling their seizures.
At what dose is Depakote typically prescribed?
Oral dosages of Depakote for epilepsy treatment typically start at 10-15 mg/kg/day, and are then increased by 5-10 mg/kg/week to achieve optimal clinical response. The total daily dose should not exceed 60mg/kg/day. In the case of Topamax, adults generally begin with a dosage of 25-50 mg/day, which can be increased over several weeks up to a maximum recommended dose of 400mg per day divided into two doses. For children and adolescents who are on this medication for epilepsy treatment, the starting dosage is usually around 25mg taken before bedtime and may be slowly incremented until an effective therapeutic level is reached. Always consult your healthcare provider who will determine the appropriate dosage based on individual patient's needs.
At what dose is Topamax typically prescribed?
Topamax treatment is generally initiated at a dosage of 25–50 mg/day. The dose can then be augmented to 100 mg/day, divided into two doses, spaced around 12 hours apart. Maximum dose is typically set at 400 mg/day divided into two equal doses of 200 mg and taken about every twelve hours, which may be experimented with if there is no significant response to the treatment at the lower dosages after several weeks. As with all medications, it's advisable to follow your doctor's instructions strictly for optimal therapeutic results and safety.
What are the most common side effects for Depakote?
Common side effects you might experience with Depakote include:
- Nausea, vomiting, and indigestion
- Drowsiness or sleepiness
- Diarrhea or constipation
- Changes in body weight
- Tremors (uncontrolled shaking of a part of the body)
- Hair loss
- Blurred vision or double vision
- Unusual bruising or bleeding
In contrast, Topamax may cause:
- Tingling in the arms and legs
- Weight loss
- Altered sense of taste -Dizziness and coordination problems, -Speech problems -Fatigue
Please be aware that both medications can also have more serious side effects that require immediate medical attention.
Are there any potential serious side effects for Depakote?
Topamax, like all medications, may cause certain side effects. Some of these are serious and should prompt immediate medical attention. These can include:
- A sudden increase in thoughts about suicide or self-harm.
- Signs of a severe allergic reaction such as hives, difficulty breathing, swelling in your face or throat.
- Any signs of a dangerous skin reaction like fever, sore throat, burning eyes, skin pain followed by a red or purple rash that spreads and causes blistering and peeling.
- Eye-related issues including blurred vision or sudden blindness; eye pain; an appearance of halos around lights; sudden decrease in vision accompanied by eye pain and redness - which could be symptoms of glaucoma (acute myopia).
- Heart complications: fast heartbeats/palpitations; fluttering sensation in the chest coupled with shortness of breath; abrupt dizziness leading to fainting spells (syncope).
- Lowered sodium levels manifesting as headache confusion slurred speech extreme weakness nausea loss coordination unsteadiness Severe reactions involving the nervous system - muscle stiffness/rigidity high body temperature sweating confusion rapid or irregular pulse tremors etc. If you experience any symptoms similar to serotonin syndrome such as agitation hallucinations fever excessive perspiration shivering accelerated heartbeat muscle rigidity twitching lack coordination along with gastrointestinal problems like nausea vomiting diarrhea seek immediate medical help.
What are the most common side effects for Topamax?
Topamax, another popular anticonvulsant medication, comes with its own set of potential side effects. These may include:
- Paresthesia (tingling or numbness), particularly in the hands and feet
- Decreased appetite leading to weight loss
- Altered taste sensation
- Fatigue and drowsiness
- Nausea or stomach pain, potentially causing a decrease in appetite
- Difficulty with memory and concentration leading to confusion
- Dizziness or loss of coordination
- A slight increase in respiratory infections like sinusitis resulting in stuffy nose
- Visual disturbances such as blurred vision.
It's worth noting that while these side effects are possible, not everyone taking Topamax will experience them. It is essential for patients considering this medication to discuss the potential risks and benefits thoroughly with their healthcare provider.
Are there any potential serious side effects for Topamax?
Topamax, while effective for many, can have serious side effects in some instances. These may include:
- Signs of an allergic reaction or severe skin reaction: rashes, hives, itching, difficulty breathing or swallowing due to throat swelling.
- Increased thoughts about suicide or self-harm
- New onset seizures or increased frequency of existing seizures
- Mental confusion and noticeable mood swings
- Visual disturbances such as blurred vision, eye pain and redness
- Rapid heart rate or palpitations
- Symptoms indicative of a metabolic acidosis (a condition that happens when there's too much acid in your body fluids), like tiredness, loss of appetite, irregular heartbeat and altered consciousness.
If you experience any of these symptoms while taking Topamax it is crucial that you reach out to your healthcare provider immediately.
Contraindications for Depakote and Topamax?
Both Depakote and Topamax, along with most other anticonvulsant medications, may worsen mood symptoms in some people. If you notice your mood worsening or an increase in suicidal ideation, thoughts, or behavior while taking these drugs, please seek immediate medical attention.
Neither Depakote nor Topamax should be taken if you are using certain medications like monoamine oxidase inhibitors (MAOIs), certain antidepressants or other seizure medicines without consulting your physician. These drugs can interact dangerously with each other which could lead to serious side effects. Always tell your healthcare provider about all the medications and supplements that you are currently taking; certain ones will require a period of clearance from the system to prevent dangerous interactions with Depakote and Topamax.
How much do Depakote and Topamax cost?
For the brand name versions of these drugs:
- The price for 60 tablets of Depakote (250 mg) averages around $650, which works out to approximately $10.83-$21.67/day, depending on your dose.
- The price for 30 tablets of Topamax (100 mg) averages about $375, working out to roughly $12.50/day.
Thus, if you are in the higher dosage range for Depakote (i.e., 1500 mg/day or higher), then brand-name Topamax could be less expensive on a per-day treatment basis. But remember that cost should not be your primary consideration in determining which medication is better suited for you.
As we move onto generic versions of these medications—the costs significantly decrease:
-
Divalproex sodium (generic version of Depakote; available in packs from 30 up to 180 capsules at doses from 125mg -500mg) will run between approximately $.40 and $3 per day based on typical dosages.
-
Generic topiramate prices also vary but fall within a similar range as divalproex sodium with an average cost ranging from $.20 and up to about $2 per day based on standard dosages.
Remember that this information may change over time and can vary by location and pharmacy; always check current prices before making a decision.
Popularity of Depakote and Topamax
Divalproex Sodium, available in generic form and under the brand name Depakote, was prescribed to approximately 3 million people in the US in 2020. Divalproex Sodium accounted for nearly 10% of all antiepileptic prescriptions last year. This medication has been fairly constant in its usage since it first came on the market, primarily used as a mood stabilizer and to control seizures.
Topiramate, including brand versions such as Topamax, was prescribed to about 4 million individuals in America during the same time period. In terms of usage among those needing seizure medications or migraine prevention drugs (two common uses), it comprises around 12% of prescriptions within that class. Over recent years there's been an upward trend observed with this drug due largely to its broader utility beyond epilepsy into areas like weight loss and migraine prophylaxis.
Conclusion
Both Depakote (divalproex sodium) and Topamax (topiramate) have well-established records of usage in patients with epilepsy and bipolar disorder, backed by numerous clinical studies indicating their effectiveness. In some cases, these drugs may be combined, but this is subject to careful consideration by a physician due to the potential for drug interactions. Their mechanisms of action differ; Depakote works primarily by increasing GABA levels in the brain while Topamax inhibits certain types of seizures through modulation of voltage-gated ion channels.
Depakote is often considered a first-line treatment option for many forms of epilepsy and as a mood stabilizer in bipolar disorder. On the other hand, Topamax would usually be considered as an adjunct therapy or used when patients cannot tolerate other antiepileptic drugs or mood stabilizers.
Both medications are available in generic form which represents significant cost savings especially for out-of-pocket payers. It's important to note that both Depakote and Topamax can require adjustment periods where effects may not become evident immediately upon starting treatment.
The side effect profiles between the two drugs vary but are generally manageable; weight gain tends to be more associated with Depakote whereas weight loss is more common with Topamax use. As with any medication affecting neurological function, it's crucial that patients closely monitor changes in moods or behaviors during treatment initiation or dosage adjustments under medical supervision.
Refrences
- Shiah, I.-S., Yatham, L. N., & Baker, G. B. (2000, July). Divalproex sodium increases plasma GABA levels in healthy volunteers. International Clinical Psychopharmacology. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/00004850-200015040-00005
- Shank, R. P., & Maryanoff, B. E. (2008, May 14). Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate. CNS Neuroscience & Therapeutics. Wiley.http://doi.org/10.1111/j.1527-3458.2008.00041.x
- Mulleners, W. M., McCrory, D. C., & Linde, M. (2014, August 12). Antiepileptics in migraine prophylaxis: An updated Cochrane review. Cephalalgia. SAGE Publications.http://doi.org/10.1177/0333102414534325
- Roy Chengappa, K., Rathore, D., Levine, J., Atzert, R., Solai, L., Parepally, H., … Brar, J. S. (1999, September). Topiramate as add‐on treatment for patients with bipolar mania. Bipolar Disorders. Wiley.http://doi.org/10.1034/j.1399-5618.1999.10111.x
- Schwabe, M. J., & Wheless, J. W. (2001, November). Clinical Experience With Topiramate Dosing and Serum Levels in Children 12 Years or Under With Epilepsy. Journal of Child Neurology. SAGE Publications.http://doi.org/10.1177/08830738010160110501
- Ferrari, A., Tiraferri, I., Neri, L., & Sternieri, E. (2011, July 15). Clinical pharmacology of topiramate in migraine prevention. Expert Opinion on Drug Metabolism & Toxicology. Informa UK Limited.http://doi.org/10.1517/17425255.2011.602067
- Faught Jr, E. (2008, January). Topiramate in the treatment of partial and generalized epilepsy. Neuropsychiatric Disease and Treatment. Informa UK Limited.http://doi.org/10.2147/ndt.s512
- Bruni, J. (1998, August). Efficacy of Topiramate. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. Cambridge University Press (CUP).http://doi.org/10.1017/s0317167100034831
- Pratico, A. D., Ruggieri, M., Falsaperla, R., & Pavone, P. (2018, June 12). A Probable Topiramate-induced Limbs Paraesthesia and Rigid Fingers Flexion. Current Drug Safety. Bentham Science Publishers Ltd.http://doi.org/10.2174/1574886313666180213090445